A company whose acquisition by Roche was completed two years ago has become the second to win a Food and Drug Administration approval for a companion diagnostic test using liquid biopsy. Cambridge, Massachusetts-based Foundation Medicine said Wednesday that the FDA had approved its FoundationOne Liquid CDx, which becomes available commercially […]